Conduct Final Residency Review and Determine Pathway
Evaluate the venture's overall performance against predetermined stage-gate completion criteria and investment readiness standards. Render a formal decision to progress the venture to the investment committee, mandate a targeted evidence-gathering repeat, or route to an alternative pathway. Formalise the transition plan and register all final assets in the central venture data-room.
Conducting this final review eliminates ambiguity regarding the venture's readiness for institutional capital or next-stage support. It safeguards programme resources by ensuring only high-conviction, fully validated ventures proceed to formal investment gates.
The output must be a signed Residency Completion Memorandum containing the formal pathway determination (Progress, Repeat, Escalate, or Pivot). A completed Investment Committee Data-Room Asset with all supporting evidence, co-founder agreements, and venture DNA updates must be archived.
Five questions an expert would ask when reviewing your output
Use these to challenge assumptions, pressure-test your logic, and check the quality of this action's output in the context of the parent task and wider venture development.
- 1
On what explicit empirical grounds has the decision to progress or halt this venture been justified?
- 2
What specific gap in the data-room asset would cause an external institutional investor to decline this deal immediately?
- 3
How does the recommended next support pathway explicitly resolve the remaining high-priority risks flagged in the final review?
- 4
If the recommendation is to repeat or pivot, what exact evidence threshold must be achieved before re-entering the gate?
- 5
How has this residency outcome definitively updated the venture DNA to ensure long-term, scalable execution?
